SPY417.26+1.39 0.33%
DIA341.86+1.53 0.45%
IXIC14,052.34+13.58 0.10%

Wells Fargo Maintains Equal-Weight on Amphastar Pharmaceuticals, Lowers Price Target to $20

Wells Fargo maintains Amphastar Pharmaceuticals (NASDAQ:AMPH) with a Equal-Weight and lowers the price target from $21 to $20.

· 03/17/2021 08:07
Wells Fargo maintains Amphastar Pharmaceuticals (NASDAQ:AMPH) with a Equal-Weight and lowers the price target from $21 to $20.